Thymosin Alpha-1 is a naturally occurring peptide derived from the thymus gland, studied for its role in modulating immune function.
🔬 Studied for: Immune-Function Research
💊 Also studied for: Vaccine & Adjuvant Research
🧪 Not FDA-approved — sold strictly for laboratory research
📈 No standardized human dosage established in published literature
Thymosin Alpha-1 is a naturally occurring peptide derived from the thymus gland, studied for its role in modulating immune function. It holds regulatory approval in several countries outside the United States (marketed as Zadaxin) for immune-related indications, though it does not have FDA approval.
Thymosin Alpha-1 is studied for its effects on T-cell maturation and function, modulating both innate and adaptive immune responses — a mechanism that has made it a subject of research in infectious disease, vaccine-adjuvant, and immune-support contexts internationally.
These are effects Thymosin Alpha-1 has been studied for in available preclinical and early research — not claims about guaranteed outcomes.
A substantial international clinical literature has examined Thymosin Alpha-1 as an adjunct treatment for hepatitis B and C and as an immune modulator in various infectious and oncologic contexts, primarily outside the US regulatory system.
Because of its studied effects on T-cell responses, Thymosin Alpha-1 has also been researched as a potential vaccine adjuvant and in contexts involving immunocompromised patients.
Dosing protocols used in international clinical trials and approved-use contexts are documented in that literature; no FDA-approved dosage exists for research-grade Thymosin Alpha-1 in the United States.
Compound X does not provide dosing recommendations. Thymosin Alpha-1 is sold for laboratory research use only and is not intended for human consumption.
Where used clinically under its international approvals, documented side effects have generally been mild, including injection-site reactions; it does not have FDA approval in the United States, and research-grade material sourced outside regulated pharmaceutical supply chains has not undergone equivalent quality controls.
No. Thymosin Alpha-1 is not FDA-approved for any indication and is sold strictly as a research chemical, not a medication or dietary supplement.
Immune-Function Research — A substantial international clinical literature has examined Thymosin Alpha-1 as an adjunct treatment for hepatitis B and C and as an immune modulator in various infectious and oncologic contexts, primarily outside the US regulatory system.
In the US, UK, Canada and Australia, Thymosin Alpha-1 is generally sold labeled "for research use only, not for human consumption." It is not approved as a dietary supplement or medication in any of these countries.
Thymosin Alpha-1 clinical research is indexed on PubMed under "Thymosin alpha 1 immune modulation" and "Zadaxin thymosin clinical trial."
Compare current prices, purity testing claims and coupon codes across every vendor Compound X tracks.
New guides, vendor comparisons and compound breakdowns every week.